CanREValue retweeted
We are "back"!! A great opportunity for new researchers: Applications for @CIHR_ICR’s Early Career Researcher (ECR) Workshop are due September 30, 2024.
Apply now: bit.ly/42dmy3e
We are looking forward to putting up our posters this afternoon at #ARCC2024. You can also view them in the conference app any anytime and send us questions there!
CanREValue will be at #ARCC2023 - we hope to connect with you there! Patients and caregivers can register for free as this event is Patients Included(tm)!
Only 3 weeks until #ARCC2023! We hope you will join us - visit cc-arcc.ca/arcc-conference-2… to find out more!
CanREValue retweeted
Registration for the 2023 ARCC Conference #ARCC2023 is Now Open! We hope to see you in September - visit cc-arcc.ca/arcc-conference-2… for info or register directly at tinyurl.com/43m9hexw
CanREValue retweeted
Today is the #ARCC2023 Abstract deadline - don't miss your chance to submit event.fourwaves.com/ce06296b… and join us this September cc-arcc.ca/arcc-conference-2…
CanREValue retweeted
Expressions of interest are being accepted to join the #AYACancerPSP. Make sure that future research on AYA Cancer in Canada is what matters most to patients, survivors, caregivers, and clinicians. survey.ucalgary.ca/jfe/form/… @ayacan_cancer @drperritutelman
CanREValue retweeted
🚨Real-World Evidence (#RWE ) Reporting Guidance is now out for consultation! 🚨
Have your say by providing feedback before Jan 6! and attend the information webinar on Dec 2.
@CADTH_ACMTS @GovCanHealth
cadth.ca/news/cadth-launches…
CanREValue retweeted
Precision oncology requires learning healthcare (LH). To realize LH, @CleoNetwork published our thoughts on the future of life cycle HTA in @Nature_NPJ: nature.com/articles/s41698-0…
Amazing work by @DeirdreWeymann and the @CleoNetwork team looking at RWE, precision oncology, and life-cycle HTA!
Check out this new paper from @CleoNetwork - "A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada" nature.com/articles/s41698-0…. ARCC is proud to have helped support this work!
The CanREValue Collaboration is excited to continue developing and working with CCRE!
Today ARCC is excited to announce the formal launch of the Canadian Cancer Real-world Evaluation platform (CCRE), a Core Network Partner with
@CADTH_ACMTS
CoLab - colab.cadth.ca. Stay tuned for more details in the coming weeks!
A fantastic opportunity to play a key role in Canadian Cancer RWE!
New CCRE Opportunity - Team Lead - Decision Scientist (Ontario Health). Please share widely with your networks to help us find the best candidate! oh.wd3.myworkdayjobs.com/en-…
Find out more about CCRE and our other opportunities at cc-arcc.ca/announcing-the-ca…
Some great opportunities to get involved in Canadian cancer RWE work! cc-arcc.ca/announcing-the-ca…
Opportunities to join the Canadian Cancer Real-World Evaluation (CCRE) Platform are now live - cc-arcc.ca/announcing-the-ca… please circulate among your networks!
CanREValue retweeted
Did you know ARCC leads the Cancer Theme Group for @CAHSPR ? Don't miss today's special session at #VCAHSPR22 starting at 10:30 ET!
All six of @CAHSPR's theme groups will be leading a session on June 2, 10:30 EDT at #VCAHSPR22. We are looking forward to the presentation by the Cancer Theme Group, which is highly relevant!
CanREValue retweeted
Today we kick off #ARCC2022 with our opening plenary at 12:00ET. We hope you can join us there!
cc-arcc.ca/arcc-conference-2… @cancerstratCA @hdrn_rrds @GovCanHealth
CanREValue retweeted
Dont miss your chance to join us for #ARCC2022 next week - there is still time to register - find out more at cc-arcc.ca/arcc-conference-2…!
CanREValue retweeted
Congratulations Rohini! ARCC is extremely proud to have assisted in this work, which we will also share @ #ARCC2022 - we hope you can join us events.eply.com/2022ARCC
Very important work using a microsimulation model of real-world population data from Ontario, Canada!
Important new work published by ARCC researchers shows that #COVID19 related slowdowns of cancer surgeries could affect long-term survival for many patients with cancer. Read the full story at cmaj.ca/sites/default/files/…
CanREValue retweeted
One week remaining before the abstract submission deadline for #ARCC2022 - we hope to see you and your work there! Submit now at event.fourwaves.com/arcc2022…
CanREValue retweeted
Abstract submission for #ARCC2022 is Now Open! Submit your abstract at pheedloop.com/ARCC2022/propo…
Find our more about the conference at cc-arcc.ca/arcc-conference-2…
CanREValue will showcase current work at #ARCC2022 - we hope you will join us there!
Announcing the 2022 ARCC Conference - #ARCC2022! We are again going virtual on May 16-17, 2022, and abstract submission will open next week. Keep up-to-date as the conference evolves at cc-arcc.ca/arcc-conference-2…








